Aim: Drug metabolic profile plays an important role in discovering and developing a novel drug from metabolites possessing pharmacological activities. Lapachol is a major active component isolated and identified from the Tabebuia avellandedae herbs, which has been found to possess many biological activities. The aim of our work is to study the metabolite structures. Methods: Nine phase I metabolites and four phase II metabolites of lapachol in rat bile were elucidated and identified by a sensitive LC-ESI-MS n method. Results: The molecular structures of the metabolites are presented on the basis of the characteristics of their precursor ions, product ions and chromatographic retention times. The results indicate that the phase I metabolites were mainly biotransformed by three main routes: hydroxylation, hydrogenation, and hydrolysis metabolism. Phase II metabolites were mainly identified as the glucuronidation conjugates which showed a characteristic neutral loss of 176 Da. The biotransformed pathways of lapachol are also proposed on the basis of these metabolite structures. Conclusion: This investigation provides the valuable information on lapachol metabolism which is essential for understanding the safety and efficacy of this compound as well as for the development of a novel drug.
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Liquid chromatography-mass spectrometry based metabonomic investigation into the potential biomarkers for acute repetitive hypoxia Hai-ting CHENG, Ming-ming WANG, Su SU, Pin-xiang XU, Ming XUE * . Department of Pharmacology, School of Basic Medical Sciences, Capital Medical University, Beijing 100069, China Aim: To identify and character the biomarkers in mice suffered the repetitive hypoxia. Methods: A metabonomic method utilizing LC-ESI-MS n and multivariate statistical technique has been successfully applied to investigate the metabolic profiles of hypoxic preconditioning in mice by the model of acute repetitive hypoxia. Both the brain and heart tissues were collected for studying the potential biomarkers via comparing the tissues from the normal mice and the hypoxic preconditioning mice. The tissue samples were analyzed by LC-ESI-MS n . After denoise, peak detection and peak alignment, the data of the metabolites were fed to partial least squares discriminate analysis (PLS-DA) and pattern recognition to find the potential biomarkers. The candidate molecules of the potential biomarkers were searched from the Human Metabonomic Database (HMDB) and METLIN databases.
Results: According to the corresponding the accurate molecular weight, retention time and tandem mass results, several potential biomarkers and their levels in the tissues were identified. The results indicated that phenylalanine, valine, proline, leucine and glutamine were increased, while creatine was decreased, both in brain and heart of the hypoxia group. In addition, γ-aminobutyric acid was markedly decreased in brain of the hypoxia group. Conclusion: The biological significance of the present study was discussed by referring to the relevant literature and databases. Keywords: metabonomics; biomarker; acute repetitive hypoxia; brain; LC-ESI-MS Acknowledgements: The authors thank the National Natural Science Foundation of China (81173121) To elucidate the effect of baicalin on the pharmacokinetics of theophylline in rats, focusing on plasma protein binding displacement and inhibitory effect on CYP1A2 in vivo and in vitro. Methods: This study was a randomized, three-period crossover design. Theophylline (5 mg/kg, iv) was administered to rats immediately following the injection of baicalin (450 mg/kg, given 1 time or divided into 3 times). The effect of baicalin on CYP1A2 activity was determined by metabolism of phenacetin and plasma protein binding of theophylline was determined by ultrafiltration in vitro. Results: C max of theophylline decreased by 30% and 31%, T 1/2 increased by 116% and 71%, V d increased by 51% and 49% in different treatment group (baicalin 450 mg/kg given 1 time or divided into 3 times), respectively. No significant effects on the CL and AUC of theophylline were observed in the rats treated with baicalin given 1 time, but the CL significantly decreased and AUC increased in the group treated with baicalin divided into 3 times compared with control (P<0.05). Baicalin inhibited metabolism of phenacetin and exhibited a mixed-type inhibition in rat liver microsomes in vitro. Moreover baicalin was a competitive displacer of theophylline from plasma protein in vitro. Methods: An open-label, parallel study was conducted. Thirty healthy subjects were randomly divided into three groups, which were sequentially treated with batifiban alone, or oral coadministration of clopidogrel, aspirin and UFH, or batifiban coadministered with these antithrombin agents. Blood samples were collected at pre-specified times. The evaluation index included the inhibition of platelet aggregation and pharmacokinetic parameters.
Results: The pharmacokinetic parameters of batifiban and batifiban coadministered with antithrombin agents showed no significant differences. The mean inhibition rate of platelet aggregation (%) suggested that neither batifiban alone nor antithrombin agents alone could provide such potent inhibition rate (>80%) to obtain the best clinical efficacy, but they have a synergistic effect on platelet inhibition. No serious adverse effects were observed. Conclusion: The results in these healthy subjects suggest that batifiban coadministrated with antithrombin agents could achieve optimum clinical treatment effect for patients with NSTE ACS, and also those scheduled for percutaneous coronary intervention. Methods: Blood and urine samples of rats that had been injected intravenously with recombinant hirudin that harbors an N-terminal amino acids sequence of ITY, and radiolabeled with 125 I ( 125 I-recombinant hirudin), were collected, separated by gel filtration chromatography, and monitored by the gamma-counter. ELISA and the chromogenic substrate assay were employed to determine immunogenicity and anti-thrombin activity, respectively, in the elutions. Elutions that exhibit antithrombin activity were further purified by reverse phase high performance liquid chromatography (RP-HPLC). The molecular weight and the amino acid sequence of the purified recombinant hirudin metabolite were determined. Results: The recombinant hirudin is metabolized in the plasma, whose metabolites, presented in the urine, exhibited the anti-thrombin activity, but not hirudin immunogenicity. The anti-thrombin metabolite of recombinant hirudin is identified to be the N-terminal polypeptide fragment of recombinant hirudin, consists of the same first 52 amino acid residues as those in the recombinant hirudin, with a molecular weight of 5162 Da. Dual chanel HPLC with two pumps, two columns and one switching valve has been developed in the last decades to do on-line SPE with direct injection of serum or plasma into the system. Three types of on-line SPE columns are commercially available: the different kinds of reverse-phase (RP) columns, restricted access material (RAM) columns and turbulent flow chromatography (TFC) columns. RP columns are easily to be contaminated and clogged, and need to be changed frequently. RAM and TFC columns function as a pre-column, in combination with an analytical column and column switching, to remove proteinaceous materials prior to analytical chromatographic separation. Many on-line SPE methods have been reported for the determination of different kinds of medications/metabolites in serum or plasma. But these methods have not been widely used, because of short on-line SPE column life-time, low drug recovery and high costs.
We have developed a new strategy by combining PP, on-line SPE and column switching together. The protein precipitation reagent we used has a very high protein removal efficiency (>99.4%), high drug extraction efficiency (>70%) and low organic solvent usage (less than the sample volumn). After centrifugation, the supernatant is directly injected into the HPLC system with large volumn (up to 1000 μL). The on-line SPE column is a short RP C 18 column, and can durate for more than 3000 injections without significant column pressure rising. Only the eluent containing the analytes is swithched into the analytical column to do further separation and detection. Most of the impurities are washed directly to the waste. We have already successfully developed several new methods for the determination of atomoxetine, clozapine, N-desmethylclozapine, quetiapine, olanzapine, risperidone and 9-hydroxyrisperidone in human serum. All these HPLC methods are highly specific, precise and accurate with long duration of the on-line SPE column, simple sample preparation and high degree of automation. Keywords: protein precipitation; on-line SPE; column switching; high performance liquid chromatography Acknowledgements: We would like to thank financial supports from the National Science and Technology Major Project for Investigational New Drug (2012ZX09303-003), Capital Medical Research Development Fund of China (2007-3087 and 2009-3135) , and the Science and Technology Innovation Platform Construction Project of Beijing Education Commission (PXM2011_014226_07_000089).
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Hepatotoxicity of pyrrolizidine alkaloid-containing natural products and development of the mechanism-based biomarker for clinical assessment Ge LIN. School of Biomedical Sciences, Faculty of Medicine, The Chinese University of Hong Kong, Hong Kong, China It is now well recognized that the concept of no adverse effect and/or toxicity of traditional Chinese medicines (TCMs) is a misnomer. Similar to orthodoxdrugs, TCMs may also induce toxicity. In this presentation, using pyrrolizidine alkaloids (PAs)-containing natural products as an example, safety of TCMs will be illustrated. PAs are widely present in plant kingdom. PAs have been detected in herbal plants, teas, and dietary supplements, and also in foodstuffs, including grain crops, honeys and milks. Yearly numerous PAs poisoning cases occur worldwide. PAs are considered as a group of natural toxins with a high risk of acute poisonings, prolonged toxicities and potential tumorigenicity. PAs are pro-toxins and induce toxicity via metabolic activation to generate pyrrolic metabolites, which are chemically reactive and react rapidly with cellular macromolecules to form pyrroleprotein adducts leading to hepatotoxicity. Due to metabolites instability, to date there are no available method to analyze them and no clinical approach to diagnose PAs intoxication. Our research team has been working on PA-induced toxicity for many years. Recently, we developed pyrrole-protein adducts as the mechanismbased biomarker and determined the min blood samples of the patients who ingested PA-containing herbs in China or who exposed to PA-contaminated food stuffs in other country, demonstrating the successful development of a biomarker for the diagnosis and assessment of hepatotoxicity induced by PA-containing herbs and PA-contaminated foodstuffs. Keywords: mechanism-based biomarker; pyrrolizidine alkaloids; hepatotoxicity; toxicity of natural products Acknowledgements: This study was supported by HKSAR (GRF grants: 471310 and 469712), CUHK (Direct Grant: 2041744), and US CDC (Grant: 7010112). To evaluate the contribution of the impaired cytochrome P450 and breast cancer resistance protein (BCRP) activity and expression to drug pharmacokinetics under diabetic states. Methods: Diabetic was induced in rats by intraperitoneal administration of streptozocin. Glibenclamide (GLB), a substrate of BCRP, served as a model drug. The pharmacokinetics of orally administered GLB (10 mg/kg) were studied. Results: Diabetes mellitus significantly increased exposure (area under the curve and peak concentration) to GLB after oral administration. Data from hepatic microsomes suggested impairment of GLB metabolism in diabetic rats. GLB metabolism in hepatic microsomes was significantly inhibited by a selective inhibitor (sulfaphenazole) of CYP2C11 and anti-CYP2C11 antibody. Western blotting further indicated the contribution of impaired CYP2C11 expression to the impairment of GLB metabolism. Excretion data showed that approximately 72% of the orally administered dose was excreted via feces of normal rats, which indicated an important role for intestinal BCRP. Diabetes significantly decreased recovery from feces, which was only 40% of the orally administered dose. Results from in situ, single-pass, intestine perfusion experiments revealed that diabetes significantly increased the apparent permeability and decreased efflux of GLB through the intestine; this suggests impairment of intestinal BCRP function, which may play a role in the increased exposure to orally administered GLB in diabetic rats. Insulin treatment partly or completely reversed the changes in diabetic rats. To study the pharmacokinetic characteristics of salvianolic acid A (Sal A) after a single oral administration in rats, including the absorption, distribution, and excretion. Methods: Rats were allocated into the following treatment groups: in the absorption experiment, rats (male/female, 1:1) were given a single oral dose of 5, 10, and 20 mg/kg and received a single dose of 50 μg/kg iv injection; rats (male/female, 1:1) in the distribution and excretion studies were given a single oral dose of 5 and 20 mg/kg, respectively. Plasma was sampled before and after administration at designated time points. Animals were sacrificed at 10 min, 1 h, and 2 h post-dosing and multiple tissues were harvested. Bile, urine, and feces samples were collected over designated time intervals. Caco-2 cell model was applied in the absorption mechanism study of Sal A. Results: After oral administration, Sal A reached the peak concentration in plasma within 1 h followed by a quick elimination. The absolute bioavailability was calculated to range from 0.39% to 0.52%, which indicated poor absorption. Besides, Sal A was shown to have poor permeability (less than 1×10 -6 cm/s) across the Caco-2 cell monolayer, and the ratio of P B-A to P A-B was greater than 1.5 at different concentrations. Sal A could distribute widely in different tissues with different concentrations. Excretion results showed that total excretion of unchanged Sal A accounted for 7.81‰ of the administered dosage. Conclusion: The pharmacokinetic properties of Sal A in rats after oral administration were characterized as a rapid oral absorption, a poor absolute bioavailability, a wide tissue distribution, and a quick but low elimination. Keywords: salvianolic acid A; pharmacokinetics; absorption; distribution; excretion Prof Kawai, Toho Univ, Japan) under the same protocol with strictly adjusted trial conditions to remove possible extrinsic bias were conducted in 4 countries; Japan, China, Korea, and USA. In contrast with previous information, no significant PK difference was observed in moxifloxacin, simvastatin, and meloxicam among these groups. These results strongly suggest the importance of the influence of extrinsic bias including diet in drug response. For example, green tea is the most common beverage in Japan and has been shown to interact with drugs by changing the pharmacokinetics and pharmacodynamics of orally administered drugs. In this symposium, we would like to briefly introduce the results from the global PK studies and the data of green tea-drug interaction as a potential extrinsic factor that may influence ethnic difference in drug response. E-mail: zhanglirongzzu@126.com Aim: To study effects of CYP3A4*1G (G>A), CYP3AP1*3 (G>A) and gender on pharmacokinetics of simvastatin and simvastatin acid. Methods: The polymorphisms of CYP3A4*1G and CYP3AP1*3 were determined by polymerase chain reaction-restriction fragment length polymorphism. Serial blood samples were obtained up to 24 h after a single dose of 40 mg simvastatin intake in healthy Chinese volunteers. Plasma concentrations of simvastatin and simvastatin acid were detected by HPLC/MS/MS. Results: Weight-adjusted apparent volume of distribution (NV d /F) of simvastin in CYP3A4*1G AA genotype was higher than that in GG genotype. However, dose-normalized by the body weight C max (NC max ) in AA genotype was lower than that in GG genotype. NV d /F of CYP3AP1*3 AA genotype was higher than that of GA genotype, while NC max of AA genotype was lower than that of GA genotype. NC max of simvastatin acid was higher in females than that in males. Conclusion: CYP3A4*1G or CYP3AP1*3 has some effects on NV d /F and NC max of simvastatin, and the NC max of simvastatin acid is higher in female than that in male. Keywords: CYP3A4*1G; simvastatin; simvastatin acid; pharmacokinetics; CYP3AP1*3 S12.29 Transportation of neuroprotective flavonoids, based on cell toxicity: a comparison using the blood-brain barrier cell and Caco-2 cell models Section 12: Metabolism of Drug npg Yu-ya YANG, Lu BAI, Chen-yang GUO, Bin-bin XIA, Xiao-rong LI, Pin-xiang XU, Ming XUE * . Department of Pharmacology, School of Basic Medical Sciences, Capital Medical University, Beijing 100069, China Aim: Comparative evaluations of the transmembrane transport of eight cerebrovascular protection flavonoids including puerarin, rutin, hesperidin, quercetin, genistein, kaempferol, apigenin, and isoliquiritigenin, based on the cellular toxicity and lipophilicity were investigated using rat blood-brain barrier cell and Caco-2 cell monolayer model. Methods: The apparent permeability coefficients (P app ) of the tested flavonoids were calculated from the unilateral transport assays in Transwell system with simultaneous determination using a HPLC method. The toxicity of the flavonoids to rat brain microvessel endothelial cell was determined by the MTT assay. Results: The toxicity orders were genistein, isoliquiritigenin and apigenin, kaempferol, hesperidin and quercetin, puerarin and rutin. The tested flavonoids exhibited time-dependent P app values in these models. The efflux mechanisms related with P-glycoprotein exist with some flavonoids and verapamil could enhance the permeation of rutin and quercetin. The position of the glycoside and hydroxyl group in flavonoids also affected the P app value. The oil-water partition coefficient and toxicity of the flavonoids modified by the number and position of the glycoside and hydroxyl group were the key determinant for the transmembrane transport. Conclusion: These findings provided important information for establishing the transport relationship and predicting the oral bioavailability of these active flavonoids. Keywords: flavonoids; blood-brain barrier; Caco-2 cell; transport; toxicity
S12.18

